Changeflow GovPing Pharma & Drug Safety Clinical trial page for NCT07511049
Routine Notice Added

Clinical trial page for NCT07511049

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected April 6th, 2026
Email

Summary

Clinical trial page for NCT07511049

View original document View source feed page

Source document (simplified)

Show glossary

Related changes

Favicon for clinicaltrials.gov OHSU Y-90 radioembolization with immunotherapy liver cancer trial
Routine Apr 06, 2026 • ClinicalTrials.gov • Pharma & Drug Safety
Favicon for clinicaltrials.gov TQD3524 Phase 1 trial targets carbapenem-resistant bacterial pneumonia
Routine Apr 06, 2026 • ClinicalTrials.gov • Pharma & Drug Safety
Favicon for clinicaltrials.gov Clinical Trial Registration NCT07511621
Routine Apr 06, 2026 • ClinicalTrials.gov • Pharma & Drug Safety

Source

Favicon for clinicaltrials.gov
ClinicalTrials.gov clinicaltrials.gov/ct2/results/rss.xml
Pharma & Drug Safety
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
GP
Instrument
Notice

Browse Categories

Agriculture & Food Safety 63 AI Regulation 3 Banking & Finance 266 Consumer Protection 44 Courts & Legal 361 Data Privacy & Cybersecurity 74 Defense & National Security 52 Education 20 Energy 101 Environment 85 Environmental Permits 1 Environmental Regulation 13 Government & Legislation 278 Healthcare 136 Housing 16 Immigration 9 Insurance 58 Labor & Employment 113 Legislative 1 Pharma & Drug Safety 104 Public Health 3 Securities & Markets 104 Securities Regulation 15 Tax 66 Telecom & Technology 47 Trade & Sanctions 124 Transportation 57

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.